Skip to main content
Clinical Trials/CTRI/2022/05/042804
CTRI/2022/05/042804Recruiting未知

A prospective interventional study to find the effectivity of Razumab by measuring macular edema pre and post intravitreal injection.

ESIC postgraduate institute of medical science and research0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • patients with diabetic macular edema or macular edema due to retinal vaso-occlussive disease with central macular thickness of less or equal to 315 micron and visual acuity of less or equal to 0.2 on LogMAR chart will be included in the study.

Exclusion Criteria

  • 1. pre existing macular scar or dystrophy.
  • 2.patients with active inflammatory and infectious diseases of the eye.
  • 3. Patients already under treatment for macular edema in other hospital.
  • 4.patients with history of recent ocular history or trauma.
  • 5. patients with history of cerebrovascular or cardiovascular comorbidities.

Investigators

Sponsor
ESIC postgraduate institute of medical science and research

Similar Trials